Skip to main content
. 2018 Jul 30;8:11424. doi: 10.1038/s41598-018-29462-y

Table 2.

Hallmark pathways enriched for DE genes and genes expressed in different proportions of samples across the P to LS phases.

GeneSet N n P-value adjusted P
DE Genes hallmark epithelial mesenchymal transition 199 89 1.21E-62 5.94E-61
hallmark estrogen response late 200 73 3.52E-44 8.63E-43
hallmark estrogen response early 200 68 5.63E-39 9.20E-38
hallmark kras signaling up 199 67 4.01E-38 4.91E-37
hallmark il2 stat5 signaling 200 62 4.69E-33 4.59E-32
hallmark hypoxia 200 61 4.19E-32 3.42E-31
hallmark apoptosis 161 50 3.81E-27 2.67E-26
hallmark xenobiotic metabolism 200 54 9.73E-26 5.30E-25
hallmark e2f targets 200 54 9.73E-26 5.30E-25
hallmark glycolysis 200 53 7.15E-25 3.50E-24
Expressed/not expressed genes hallmark estrogen response early 200 39 2.33E-14 5.70E-13
hallmark estrogen response late 200 39 2.33E-14 5.70E-13
hallmark e2f targets 200 38 1.15E-13 1.89E-12
hallmark kras signaling up 199 36 2.21E-12 2.71E-11
hallmark epithelial mesenchymal transition 199 35 1.00E-11 8.17E-11
hallmark apical junction 199 35 1.00E-11 8.17E-11
hallmark myogenesis 200 32 8.68E-10 6.08E-09
hallmark xenobiotic metabolism 200 29 4.69E-08 2.56E-07
hallmark g2m checkpoint 200 29 4.69E-08 2.56E-07
hallmark kras signaling dn 200 27 5.55E-07 2.72E-06

N is the total number of genes in the pathway and n is the number of DE or expressed/not expressed genes in the pathway.